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Abstract

Molecular dynamics simulations were performed on the influenza A nonstructural protein 1 (NS1) RNA binding domain (RBD), a homodimer. Fourteen
simulations were performed at 298K, nine ionized with 0.1M KCl and five with no ions.
Several analysis techniques were employed to study RBD residue flexibility. The focus
of the study was the RNA binding cavity formed by side chains of helix 2 (chain A) and
helix 2’ (chain B) and cavity intermonomeric salt bridges. Opening of the salt bridges
D29-R46’ and D29’-R46 was observed in several of the trajectories. The RNA binding
cavity has large flexibility, where the dimension and shape change during the dynamics.
One pair of residues surrounding the cavity and necessary for RNA binding, residues R38
and R38’, have motions during the simulations which cover the top of the cavity. There is
correlation between the salt bridge breaking, flexibility of R38 and R38’, and the cavity
size and shape changes. Possible RBD small molecule drug targets are these two salt
bridges and the pair R38 and R38’. Disrupting the events that occur around these areas
could possibly inactivate RNA binding function of the domain. These results could have
implications in searching for potential molecules that effectively treat influenza A.

x

Chapter One
Introduction

1.1 Influenza Virus and its Impact on Humans
The human influenza virus is a major cause of illness affecting millions
worldwide with mortality rates in the hundreds of thousands each year (WHO 1). The
influenza virus is a RNA virus of the family Orthomyxoviridae that contains several
genera with influenza A being the most deadly. The influenza virus targets cells of the
respiratory tract leading to common flu associated symptoms such as fever, cough,
headache, and body aches. A common complication of the flu is viral or bacterial
pneumonia, a more severe respiratory infection that can cause death, especially in
children and the elderly (Wright). While all influenza A virus strains can be traced to the
first collected sample in 1918-1919, the virus mutates rapidly and intermingles with other
strains in different animal hosts. There are three animal hosts that carry influenza that
infects humans: human origin labeled H3N2 and H1N1, avian origin labeled H5N1, and
swine origin labeled H1N1. The labels are an identifier for the hemagglutinin (H) and
neuraminidase (N) proteins (Wright). The H5N1 is transferred among birds with
occasional avian to human transfer, which can lead to death in humans. Millions of birds
have been killed since the outbreak of H5N1 in 1997. Between October 31, 2003, and
March 19, 2012, there were 597 laboratory confirmed human cases of infection and 351
1

deaths from H5N1 (WHO 2). If the virus mutates to a form that can be transferred from
human to human, a pandemic could result similar to the Spanish flu in the early 20th
century that killed millions. The swine origin H1N1 (A(H1N1)pdm09) was detected in
April 2009, and cases were quickly reported in several countries. Although previous
swine origin influenza viruses were not easily transmitted to humans, this H1N1 strain
was easily transmitted from human to human, and a pandemic was reached in 2009
(Garten). As of August 6, 2010, more than 214 countries reported cases of
A(H1N1)pdm09, which has caused over 18,449 deaths worldwide (WHO 3). While most
human origin influenza deaths occur from secondary infection, deaths from H5N1 and
A(H1N1)pdm09 are usually caused from the virus itself, stressing the need for effective
treatment against any and all strains of influenza A (Das).

1.1.1 Current Treatment Options
Typically the symptoms associated with infection from human origin influenza A,
or seasonal flu, are treated. Effective treatments that target the virus have been difficult to
develop due to a variety of factors. Inactivated virus vaccines, made each year from a
combination of three of the most prevalent different inactive strains of the virus, are
usually effective against a few strains, but not all. Live virus vaccines seem to help
children and adults develop resistance to the yearly transmitted flu virus. The patient
develops minor respiratory tract complications, but their own immune system develops
antibodies, gaining immunity to the yearly transmitted flu virus, but usually only for that
year’s version of the virus (Wright). Vaccines exist for the seasonal flu, H5N1, and
A(H1N1)pdm09, and people are being asked to get one or more of the different vaccines
2

for increased protection (WHO 1). Effective antiviral drugs exist that target the influenza
A M2 protein, amantadine and rimantadine, and the neuraminidase protein, oseltamivir
and zanamivir, but the patient can acquire resistance to these drugs due to the high
mutation rate of the genes that express these proteins. The neuraminidase inhibitors are
approved for use against both H5N1 and A(H1N1)pdm09, although no antivirals
currently exist specifically for these strains. A protein that is highly conserved across all
influenza A strains would make a good target for a new antiviral drug. The influenza nonstructural protein 1 (NS1) is highly conserved across strains and is a potential target of
treatment for multiple strains (Yin). Recently, potential antiviral drug molecules have
been identified that inhibit the NS1 protein in vitro, but more work is needed to produce
antivirals for human ingestion (Basu, Walkiewicz, and You).

1.2 Infection
In the host respiratory tract, hemagglutinin (HA) glycoproteins of influenza
viruses bind to sialic acids on the surface of epithelial cells. The virus enters the cell
through clathrin-mediated endocytosis. In the acidic environment of the endosome the
viral envelope fuses with the endosome membrane. Structural changes in HA proteins
cause viral uncoating to occur and the release of the contents of the viron into the
endosome. Next, the M2 protein mediates release of viral ribonucleoproteins (vRNP)
from the M1 protein. The vRNPs are combinations of RNA and proteins. The influenza
vRNPs contain a nuclear localizing signal (NLS), causing the import of the vRNPs into
the nucleus of the cell. The viral RNA (vRNA) is separated from the protein and released
into the nucleus. The RNA polymerase complex is necessary for the synthesis,
3

transcription, and replication of viral messenger RNA (mRNA). The vRNA binds to
polymerase basic protein 1 (PB1), causing the polymerase basic protein 2 (PB2) to bind
to host pre-mRNAs, and the viral mRNA is transcribed. New vRNP complexes are
formed in the nucleus and exported to the cytoplasm. A budding process occurs at the
cellular membrane, where the membrane envelops the vRNPs, causing buds (viral cells)
to form which are released from the cell. The virus has now successfully replicated by
hijacking the host replication machinery and using it for viral replication (Palese).

Figure1.1 Life cycle of the influenza virus in a host cell. (Lamb)

4

1.3 Non-structural Protein 1 (NS1)
Influenza A contains eight segments of single-stranded RNA (ssRNA), with
segment 8 encoding NS1. NS1 is essential to inhibition of the host immune response as it
suppresses the host type 1 interferon (IFN) (Palese). IFN is a protein produced by host
cells in the presence of dsRNA, the indicator of an invader. NS1 binds non-specifically to
double-stranded RNA (dsRNA) as well as specific protein targets (Lin). NS1 is
composed of two domains, the C-terminal effector domain and the N-terminal RNA
binding domain (RBD). The effector domain inhibits the host cell from using its protein
synthesis machinery on host mRNAs by binding the cleavage and polyadenylation
specificity factor (CPSF) and inhibiting poly(A)-binding protein (PAB II) function. These
actions inhibit the maturation and exportation of the host cellular antiviral mRNAs. The
effector domain also sterically mediates the binding of the RBD to RNA. The RBD binds
to dsRNA, which interferes with the IFN host response, by blocking the activation of the
2’-5’-oligo(A) synthetase/RNase L pathway (Lin).

1.4 RNA Binding Domain (RBD)
The focus of this work is on the human influenza A NS1 RBD, which binds to the
host RNA allowing virus replication. The RBD is a symmetric homodimer. Each
monomer, chain A and chain B, is composed of 73 residues with three alpha-helices
(Figure 1.2). An NMR structure of the dimer (PDBID 1NS1) (Chien) and a crystal
structure of the monomer excluding residues 71 to 73 (PDBID 1AIL) (Liu) of influenza
A/Udorn/72 have been deposited in the Protein Data Bank (PDB) (Berman). The

5

monomers first dimerize and then bind to the host RNA (Palese), with residues 71 to 73
required for dimerization (Liu).

Figure 1.2. Influenza A NS1 RBD dimer structure from the PDB. Labels 1, 2, and 3 are the
helices of chain A and 1’, 2’, and 3’ the helices of chain B. RNA binds to helices 2 and 2’. The
effector domain is located at helices 3 and 3’. Backbone residues: acidic (red), basic (green), nonpolar (pink), and polar (grey). Left panel: side view. Right panel: bottom view.

Figure 1.3 gives a representation of the locations of the alpha helices in the
sequence. Chien et al proposed that the RBD binds to dsRNA along helices 2 and 2'
(Laskowski). This hypothesis was confirmed later by Yin et al, who indicated a cavity

composed of the side chains of the 2 and 2’ helices, to which RNA binds at an
approximately 45° angle. A single-stranded 16-nucleotide RNA was experimentally
6

bound to the RBD from influenza A/Udorn/72 and characterized by NMR (BMRB
accession number 15117). Additionally, a computational model of canonical A-form
dsRNA docked to the RBD was prepared and energy minimized (Yin). This model
depicted two potential binding modes, one at the major groove of dsRNA and the other at
the minor groove, with a major groove binding mode most probable. The distance of
spacing for the phosphate groups of RNA was determined to be approximately 10Å for
the major groove and approximately 17Å for the minor groove. They determined that the
distance of spacing for the positively charged residues surrounding the cavity to be
approximately 10Å. The NS1 RBD experimentally bound to RNA and characterized by
x-ray crystallography has been deposited in the PDB, PDB ID 2ZKO (Cheng).

Figure 1.3. WirPlot for one monomer of 1NS1. Chains A and B are identical. Chain A includes
the residues 1-73: helix 1, 3-24; helix 2, 31-50; helix 3, 54-70 and chain B includes the residues
74-146: helix 1, 76-97; helix 2, 104-123; helix 3, 127-143, also denoted residues 1’-73’: helix 1’,
3’-24’; helix 2’, 31’-50’; helix 3’, 54’-70’. (Laskowski)

The goal of this study is to investigate, through molecular dynamics (MD)
simulations, potential targets in the RBD where small molecules can bind and disrupt its
function. The residues important for dimerization, D12, R19, D29, R35 and R46, have
been identified by site-directed mutagenesis (Wang). The first part of this work focuses
on the intermonomeric salt bridges between the 2 and 2’ helices that are required for
dimerization (Chien). Residues critical for RNA binding, T5, P31, D34, R35, R38, K41,
7

G45, R46 and T49, which are strongly conserved in the RBD's of all influenza A viruses,
have been identified by 1H/15N NMR chemical shift perturbation data (Yin). The second
part of this study focuses on the side chain flexibility of these residues and on the
flexibility of the RNA binding cavity formed by helices 2 and 2’ (Yin).

1.5 Summary
The NS1 RBD is conserved across strains of influenza A, making the domain a
good target for new antiviral drugs. The initial aim of the project was to run MD to find
side chains flexibility in the RBD, using the mutagenesis studies (Chien) as a guide. Once
the RBD binding data (Yin) was published, focus was shifted to binding cavity
flexibility.
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Chapter Two
Molecular Dynamics Simulations

2.1 Background
MD is a computational tool used to simulate the motions of (macro) molecules in
an environment similar to the ones used in laboratory experiments. Typically the
molecule is inserted into an implicit or explicit solvent, usually water, with or without
added salts. Algorithms have been developed to control independent variables that would
be controlled in the laboratory, such as temperature and pressure. There are different
ensembles that are employed to control variables, including the NVT ensemble: constant
number of molecules, volume, and temperature; and NPT ensemble: constant number of
molecules, pressure, and temperature. The system, started at time 0, is then set in motion
by applying random velocities to each atom. The simulation is broken up into timesteps,
and different random velocities are applied at each timestep. The three-dimensional
positions of and velocities on each atom are stored before and after each timestep,
producing a trajectory, or path of the atom motion in space. There are methods to make
some (or all) of the atoms rigid, but the most accurate method is to allow all atoms to be
in motion, which is also the most computationally expensive method. There are many
observables outputted during these simulations, so a researcher must extract the pertinent
data from the output.
9

MD is based on classical mechanics, which is the study of objects in the
macroscale, governed by Newton’s Second Law,

(1)
where F is force, m is mass, and a is acceleration. The MD simulations in this study were
performed on a Beowulf Cluster using NAnoscale Molecular Dynamics (NAMD)
Software (Phillips). Only the techniques of NAMD that were used in this study will be
described here, which are taken from Phillips, et al (Phillips), a thorough overview of the
available techniques for NAMD simulations.
Movement of atoms in a NAMD simulation is governed by Newton’s equations of
motions, specifically,

(2)
where m is mass, r is position, and U is potential energy. Force is the negative derivative
of the potential energy. The force on all particles in a system must be calculated and is
computationally expensive, so potential energy calculations are utilized in NAMD
because of the decreased computational time at which the force is calculated. The atoms
and molecules in an MD simulation must have an accurate representation of their
interactions, given by a force field.
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There are several forces of interactions that must be calculated to accurately
perform a simulation. NAMD uses this potential energy function to represent Utotal in
Equation 2:

.

(3)

The first three terms involve bonded interactions. Ubond represents stretching of each
covalent bond, Uangle represents bending of the angles made up of three atoms with two
covalent bonds, and Udihedral represents atoms separated by exactly three covalent bonds
with the central bond subject to a torsional angle, with the equations given by

(4)

(5)

(6)
where k is a force constant respective to each interaction, i is the current state of a
particular atom, Oi is the initial state of a particular atom, θ is the bending angle, ф is the
torsion angle.
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The last two terms involve non-bonded interactions. Van der Waals forces are
represented by UvdW, and are approximated by a Lennard-Jones potential. Electrostatic
interactions are represented by UCoulomb. The equations are given by

(7)

.

(8)

In UvdW, i and j are the atom indices, ε is the depth of the potential well, σ is the distance
at which the inter-particle potential is zero and r is the distance between the particles. In
UCoulomb, i and j are the atom indices, q is the charge of the atoms, ε0 is the electric
constant and r is the distance between the particles.
The algorithm used in NAMD for temperature control in the NVT and NPT
ensembles (both used in this work) the (stochastic) Langevin equation, given by

(9)
where M is mass, v is velocity, F is the force, r is the position, γ is the friction coefficient,
kB is the Boltzmann constant, T is temperature, and R(t) is a univariate Gaussian random
process. The first term on the right side of the equation is the applied force, the second is
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the frictional force, and the third encompasses random forces acting on an atom. The
system is coupled to a heat bath, where the temperature is controlled by Equation 9.
Pressure is controlled in the NPT ensemble by the Langevin-piston method, where the
system is coupled to a piston, with the pressure from the piston controlled by Equation 9.
The Langevin and Newton equations give forces and potential energies as output, but the
equations must be integrated to give the necessary positions and velocities to produce the
trajectory. Full integrations are very computationally expensive, so iterations of the
equations are employed.
Integration in NAMD is done by Verlet type algorithms, given by

(10)

(11)
where, r is distance, v is velocity, t is time, m is mass, f is a function of time, and O is the
second and higher order terms of the equation (Frenkel). The specific method used in
NAMD to integrate the Langevin equation is the Brünger-Brooks-Karplus (BBK)
method, a method based on the Verlet method (Phillips), given by
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.

(12)

2.2 Simulation Parameters
The CHARMM all-atom force field version all22_prot parameter and topology
files were used in all of the simulations (MacKerell). Visual Molecular Dynamics (VMD)
was used to prepare the systems and visualize the dynamics of the protein (Humphrey).
An explicit solvent TIP3P water box with 10Å padding was used to solvate the domains
(Jorgensen). The online tool ProtParam (Gasteiger 1) of the Expert Protein Analysis
System (ExPASy) proteomics server calculates protein parameters such as the theoretical
isoelectric point (pI), which is the pH where a molecule or surface carries no charge
(Gasteiger 2). The pI of the monomer (residues 1 – 70) was found to be 9.04, and the pI
of the dimer was found to be 7.09. The NS1 protein is found in the cytosol of superficial
cells of the respiratory tract (Wright) where the intracellular pH is typically 7.2 – 7.3.
Intracellular K+ concentration is about 0.1M, so this concentration of KCl was added to
the protein and water box (Karp). Simulations were setup by first minimizing the
potential energy of the aqueous protein by conjugate gradient. This was followed by
heating using velocity reassignment from 0K to the desired temperature with a step size
of 0.001K and equilibration by velocity rescaling at constant temperature and volume
(NVT). The trajectories for analysis were obtained using a 2fs timestep, performed using
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Langevin dynamics at a constant temperature (simulation-dependent) and pressure of
1.01325bar (NPT) and a timestep of 2fs (Feller). Periodic boundary conditions were used,
with a cubic box length of 62Å and a cutoff of 12.0Å for the short-range Lennard-Jones
interactions (Frenkel). The particle mesh Ewald sum method was used for the
computation of the electrostatics interactions, with 64 grid points in each direction, giving
a grid spacing of less than 1Å (Darden, Essmann).

2.3 Monomer

Figure 2.1. Influenza A NS1 RBD monomer from the PDB structure. Labels 1’, 2’ and 3’ are the
helices of the monomer, with the prime designation to relate to the orientation of Figure 1.2.
Backbone residues: same color scheme as Figure 1.2. Left panel: side view. Right panel: bottom
view.

The structure of the first 70 residues NS1 was exported from the PDB, PDBID
1AIL (Liu). VMD was used to add hydrogen atoms to the residues in the crystal
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structure. This fragment of the domain carries a positive 2 charge, determined by VMD.
The theoretical pI calculated with ProtParam on the ExPASy server (Gasteiger 1), 9.04,
indicates the domain would have a positive charge at physiological pH. The addition of
0.1M KCl balanced the charge of the system to zero and kept consistency with the dimer
conditions. Simulations were performed at 298K, 308K, and 318K, all for 10ns each. The
RBD exists as a dimer in solution and the results for the monomer simulations did not
give any insight to the dimer motions, so these results are not given.

2.4 Dimer
The structure of the RBD was exported from the PDBID 1NS1 (Figure 1.2). The
first of the sixteen NMR structures was used in the simulations, model 1. Figure 2.2 has
the RMSD values for each of the models compared to each of the other models. The
choice of model 1 as the initial MD structure was validated by these RMSD values, as
well as RMSD values from other comparison structures, discussed in Chapter 5.

Figure 2.2. RMSD comparing all 16 structures from the PDB structure 1NS1.
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2.4.1 Higher Temperatures
The dimer carries no net charge, determined by VMD and the theoretical pI from
ProtParam (Gasteiger 1), 7.09. While no salt was needed for charge balance of the
system, 0.1M KCl was added to maintain a similar environment in all of the monomer
and dimer simulations. Simulations were run at 298K, 308K, 318K, 338K, 358K, and
368K, all for 10ns each. The aim of the temperature increases was to denature the protein,
but this did not occur at any of the temperatures during this short time frame, so these
results are not given.

2.4.2 Mutations
VMD was used to make residue mutations for specific residues that are important
for RNA binding and dimerization. Glutamic acid mutated to alanine for residue 29 (29’),
arginine to alanine for residues 46 (46’) and 38 (38’) (Chien, Yin). These mutations were
made separately, and a 10ns simulation was performed for each mutation. This was done
to relate to the mutagenesis studies performed on the RBD, specifically to affect dimer
stability in the presence of these mutations. The dimer did not lose stability in any of the
simulations, as it did in the experimental work (Wang). The experimental results started
with monomers, made the mutations and then analyzed if the dimer was formed. These
computational results started with the dimer, made the mutations, and then analyzed if the
dimer separated into monomers.
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2.4.3 Simulation Length Extension
It was determined that 10ns simulations were insufficient in length, so the
simulation at 298K was extended to 50ns (run1). Two more simulations were started
from the same equilibration conformation of run1, with independent dynamics runs (run2
and run3). The initial velocities for the dynamics runs were given different values, giving
the independent runs. Three independent simulations were performed (run4, run5, and
run6), each started from its own minimization step. These were done to determine the
validity of the runs started from the same equilibration step. Three more simulations were
performed, run 7 from the equilibration step of run4, run8 from the equilibration step of
run5, and run9 from the equilibration step of run6. These were performed to ensure that
motions observed were characteristic of the RBD, and not an anomaly, since no other
molecular dynamics studies on the RBD could be found to compare.

2.4.4 Simulations without KCl
To determine the effect of the salt, 0.1M KCl, on the dimer system, simulations
were performed with the NS1 RBD in a water box, without the salt, for 50ns each.
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Chapter Three
Data Analysis Tools for Dynamics Production Runs

3.1 Distances between Atoms
A program written in Tool command language (Tcl) scripting language was
created to quantify the movement of atoms in relation to each other. These distances
correlate with the flexibility between different residues in the domain. This program
measures the distance between the center of an atom and the center of another atom for
each step in the simulation. The first 60ps of the MD production runs was not used for
this analysis because the system was relaxing from the change in ensembles, equilibration
(NVT) to dynamics (NPT). Data was recorded every 1ps in the simulation. This data was
plotted and smoothed using Fast-Fourier Transform (FFT), with 100 points for the
averaging, in Origin (Yang).

3.2 Principal Component Analysis
Principal component analysis (PCA) is a mathematical method used to reduce
variables (dimensionality) in a problem. In a simulation, there are 3N variables for each
timestep, where N is the number of atoms. A program was created in C to compute the
principal components of the motions of the alpha carbons of the residues of the RBD, so
that the dominant motions of the domain could be observed. Alpha carbons of the
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residues, instead of every atom of the domain, were used in this analysis to reduce
dimensionality, giving 3AC variables instead of 3N, where AC is the number of alpha
carbons. Eigenvectors of correlation matrices generated by PCA may be visualized.

3.2.1 Correlation Matrices
A correlation (covariance) matrix was used to evaluate correlated motions during
the dynamics. The matrix elements of the corresponding correlation matrix are given by

(13)
Cij is the correlation between the movement of the atoms i and j, r is the vector position
of the atoms, <...> is the average over the entire trajectory, and σi is the variance of the
position for atom i. Using the dot product of displacements from average positions in this
equation only takes into account the non-orthogonal motions. Orthogonal motions
contribute a correlation value of zero. This matrix was calculated along the length of the
entire trajectory.

Correlations are calculated motions occurring in the same direction:









Anticorrelations are calculated motions occurring in the opposite direction:









Figure 3.1. Depiction of correlations and anticorrelations of motions.
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Correlated motions, in the same direction, are positive, while uncorrelated
motions, in different directions, are negative. The matrix was normalized so that the
correlation of an alpha carbon with itself is one (Figure 3.1).

3.2.2 Eigenvectors
PCA was then used to compute the eigenvectors and eigenvalues by diagonalizing
the correlation matrix. The first eigenvector corresponds to the most dominant motion of
the protein. The first eigenvector was projected onto the alpha carbons of the domain to
plot the first eigenvector. The first three eigenvectors were analyzed because they are the
top three dominant motions of the protein.

3.3 Hydrogen Bonds
Hydrogen bond analysis was done using the program Chimera (Pettersen). The
hydrogen bonds were calculated at every 10ps for residues 29(29’), 38(38’), and 46(46’).
Simple programs were written in C and Perl to tabulate the raw data as a count for each
residue, giving counts for intramonomer, intermonomer and water/residue hydrogen
bonds. This data was plotted and smoothed using FFT, with 100 points for the averaging
(Yang).

3.4 Normal Mode Analysis
Normal mode analysis (NMA) was performed on the initial NMR structure used
for the MD simulations. The OPLS-2005 force field in the Macromodel package
(Schrödinger 1) was used to compute the lowest frequency vibrational modes. These
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modes were visualized with Maestro (Schrödinger 2) and VMD. Macromodel uses a
Large Low-MODe conformational search (LLMOD) method (Kolossváry) for normal
mode determination. First the structure was energy minimized using the Limited
Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) algorithm for 1000 iterations with a
convergence criterion of 0.0500kJ/Å·mol (Nocedal). This minimized structure was
subjected to another 500 iterations of L-BFGS (convergence 0.0500kJ/Å·mol). Then 21
modes associated with the lowest eigenvalues of the Hessian matrix were approximated,
with the rotational and translational modes ignored. PCA was performed separately on
each of the first three modes, as described in Section 3.2. The first eigenvector for the
first three modes was plotted against each alpha carbon.

3.5 Cavity Volume Determination
Volume of the binding cavity was computed using Computed Atlas of Surface
Topography of proteins (CASTp), an online volume calculation program (Liang), which
uses the CAST method (19). Different methods of volume calculation have been
evaluated previously (Chakravarty), and CAST is one of the more accurate and reliable
methods. CASTp calculation was performed with a probe radius of 1.4Å. Snapshots from
a particular run were stored as pdb structures and uploaded into CASTp, giving timedependent cavity volume calculations for that run. These volumes were plotted, giving a
cavity volume versus time plot for the run.
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Chapter Four
Dimer 298K Sample Run Analysis

Figure 4.1. Two molecular snapshots from run2. The salt bridge between residues D29 and R46’
is intact (left) and broken (right). The salt bridge D29-R46’ is displayed in the forefront. Left
panel: 0.5ns. Right panel: 12ns. Backbone residues have the same color scheme as Figure 1.2.
Side-chain residues: arginine (orange), aspartic acid (purple), lysine (light blue), and serine
(yellow).

4.1 Distances
Figure 4.1 illustrates the more important residues for dimerization and RNA
binding of the NS1 RBD according to experimental evidence (Chien). RNA binds to this
domain at helices 2 and 2’, angled approximately 45° to their direction in the major
groove (Yin). The labeled residues of Figure 4.1, except for D29 and D29’, are part of the
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cavity described by Yin et al. The arginine residues R38 and R38’ are long and flexible
and are used here as a partial measure of the deformation of the cavity formed by helices
2 and 2’. The lysine residues K41 and K41’ are long and flexible, but the side chain
nitrogen atoms of these lysine residues are usually forming hydrogen bonds with the
backbone oxygen atoms of the nearby residues R37 and R37’ during the entire trajectory
(results not given) and do not display a large flexibility during the simulations. Figure 4.1
displays typical molecular snapshots of the protein before (left panel) and after (right
panel) the D29-R46’ bridge is broken. Figure 4.2 displays the largely flexible distance
between residues R38 and R38’ far apart (left panel) and close together (right panel) at
different snapshots during the simulation. The RBD in five of the nine simulations have
large flexibility, while in the other four residues R38 and R38’ mainly stay far apart
(Appendix A).
Figure 4.2 is a 3-dimensional view of the RBD cavity, with the same orientation
as the right panel of Figure 1.2. The flexible residues change the size and shape of the
cavity. The specific residues that are labeled are the same residues as in Figure 4.1. The
RNA binding cavity is at the center of both images, and the labeled residues are the
border of the cavity. The salt bridge, D29-R46’, interaction is flexible and breaks during
the timescale of the simulations. The intact salt bridge is displayed at the top of Figure
4.2 (left panel), with R46’ interacting with D29. When the salt bridge is broken (right
panel) D29 moves to the back and away from R46’.
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Figure 4.2. Space-filling molecular snapshots corresponding to the configurations in Figure 4.1.
Left panel: salt bridge D29-R46’ intact. Right panel: salt bridge D29-R46’ broken. When D29R46’ is intact, R38 and R38’ are farther apart and when D29-R46’ is broken, R38 and R38’ are
closer together.

Figure 4.3 is a measure of the distance between residues during the entire
simulation run5. There is variability in the distance that separates residues R38 and R38’
throughout the simulation (Figure 4.3A). When these residues are far apart, the RNA
binding cavity is in an open conformation (Figure 4.2, left panel), and when they are
close together, the cavity is in a closed conformation (Figure 4.2, right panel). The
experimentally bound structure of RNA to RBD displays the open and closed
conformation of the cavity, open before RNA binds and closed when RNA binds
(Cheng). The salt bridge, D29-R46’, (Figure 4.3B) breaks during the first 10ns of the
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simulation. When the salt bridge is intact, the residues R38 and R38’ are far apart. They
get closer when the bridge is broken, thus there is correlation between the breaking of the
D29-R46’ salt bridge and the interaction of R38 and R38’.

A.

B.

C.

D.

Figure 4.3. Distance versus time for run5. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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This salt bridge breaks in seven of the nine simulations and does not reform. In
one of the nine simulations, the salt bridge D29’-R46 breaks and in one of the nine,
neither breaks. The only difference between the simulations with salt and without salt are
that the D29’-R46 salt bridge breaks in the simulations without salt more frequently. This
is essentially a labeling issue for the software, as the RBD is a symmetric homodimer.
For the simulations without salt, in three of five the salt bridge D29’-R46 breaks, and the
D29-R46’ does not break (Appendix A). Two other salt bridges that are important for
dimerization (Wang), D12-R35’ (Figure 4.3C) and D39-R35’ (Figure 4.3D), also break
during the simulation. These salt bridges were studied, but as they are on the interior of
the domain and less solvent exposed, they were considered to be less accessible, and
therefore, less important than the D29-R46’ salt bridge. There is correlation between
D29-R46’ and D12’-R35 breaking, as well as some correlation between the salt bridge
breaking events and the approach of residues R38 and R38’. When the salt bridge first
breaks at 6ns, the distance between R38 and R38’ decreases, and when the salt bridge
residues approach each other at 30ns, R38 and R38’ are farther apart. It is not clear which
event affects the other, but it appears that the nearing of R38 and R38’ affects the
stability of the salt bridge interactions, causing them to break.

4.2 Cavity Volume
As observed in Figure 4.2, while R38 and R38’ are farther apart, the cavity is
open at the center, but when the residues come close together, the cavity is essentially cut
in half from the top. The CASTp server was used to calculate cavity volume of the PDB
structure, the static RBD structure from which the binding cavity was characterized (5),
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giving the RNA binding cavity volume as 1016 Å3 (18). When distance plots for the salt
bridge(s) and residues R38 and R38’ (Figure 4.3) are compared with Figure 4.4,
correlation between salt bridge breaking events and cavity volume increasing occurs.
There is some correlation between the increasing cavity volume and increase in distance
between R38 and R38’. With the helices farther apart, there is more volume on the
interior of the cavity, as well as more volume around the location of the broken salt
bridge(s). One simulation that was used for cavity volume determination did not have a
large change in cavity through the entire simulation (Appendix B) and the salt bridge
D29-R46’ did not break during the simulation (Appendix A).

Figure 4.4. Cavity volume for run5 calculated with the CASTp server.

4.3 Hydrogen Bonds
Plots of the total number of hydrogen bonds involving residues D29 and R46’
versus time are given in Figure 4.5. The hydrogen bonds have been categorized as
intramonomer and intermonomer hydrogen bonds, and hydrogen bonds formed with
water. Figure 4.5A has the number of hydrogen bonds formed by D29 and Figure 4.5B
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has the hydrogen bonds for R46’. In both of these plots, as the intermonomer hydrogen
bonds decrease during the first 10ns, the water hydrogen bonds increase.

A.

B.

C.

D.

Figure 4.5. Hydrogen bonds for selected salt bridge residues of run5. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.

For D29, the number of intramonomer hydrogen bonds increase slightly as the
intermonomer hydrogen bonds decrease. For this trajectory, the salt bridge D29-R46’
breaks during the first 10ns (Figure 4.5, right panel). The average total number of
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hydrogen bond interactions for D29 is 8 for the first 35ns, while for R46’ the average
total is 7 for the first 35ns. During the first 10ns for R46’, the average total is 8, which
may be a factor in the breaking of the salt bridge. The 8th interaction may affect the
stability of the salt bridge, aiding the breaking, such that R46’ pushes away from D29 in
order to reduce the number of hydrogen bond interactions. All of the intermonomer
hydrogen bonds for R46’ are bonds with D29 when the salt bridge is intact. D29 forms
the remaining hydrogen bonds with S8’ and a few with N4’. The intramonomer hydrogen
bonds for D29 are formed with A30, F32, and L33. The intramonomer hydrogen bonds
for R46 are formed with S42’ and L50’. All of the other trajectories have results that are
qualitatively similar, in that as the number of intermonomer hydrogen bonds decrease, the
number of water hydrogen bonds decrease as well as the reverse (Appendix C).

A.

B.

Figure 4.6. Hydrogen bonds for residues R38 and R38’ of run5. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure 4.6 has plots of intramonomer hydrogen bonds, intermonomer hydrogen
bonds and hydrogen bonds formed with water for residues R38 (left panel) and R38’
(right panel) for run 5, although the total intermonomer hydrogen bonds is essentially 0
throughout the simulations (Appendix C). The average total number of hydrogen bonds
for R38 and R38’ is 8. As R38 and R38’ get closer together, the intramonomer hydrogen
bonds decrease, and the hydrogen bonds with water molecules increase. During the time
frame when the D29-R46’ breaks (Figure 4.3B), two intramonomer hydrogen bonds
involving R38 are broken and are replaced by two hydrogen bonds with water. When
R38 and R38’ get farther apart (Figure 4.3A), two R38 hydrogen bonds with water are
broken and two intramonomer hydrogen bonds are formed (Figure 4.6, left panel). In this
simulation, the R38’ hydrogen bonds are unaffected by the salt bridge breaking event and
the distance change between R38 and R38’. All of the simulations have similar results in
that either R38, R38’, or both swap intramonomer hydrogen bonds for ones with water
when the two residues come closer (Appendix C). When the residues are farther apart, the
hydrogen bond interactions swap back: hydrogen bonds with water become
intramonomer hydrogen bonds.

4.4 Correlation Matrices
Correlation matrices were computed for the alpha carbons of all the MD
trajectories. Figures 4.7 and 4.8 are graphical representations of the correlation matrices
for the entire simulation and the 10ns time frames of run5. Figure 4.7, left panel, plots the
correlations for the entire 50ns trajectory, and the right panel is the first 10ns time frame,
when the salt bridge breaks. The salt bridge D29-R46’ in run5 breaks during the first
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10ns (Figure 4.3). During the first 10ns the intramonomer alpha carbon correlations differ
for monomers A and B. The turns for both are mixed, with positive and negative
correlations. In monomer A, the correlation between helix 1 and helix 2 is largely
positive. Helix 1 to helix 3 and helix 2 to helix 3 are mixed, positive and negative. Helix
2 to helix 3 is largely negative. In monomer B all of the alpha helix pairs are mixed, but
mostly positive. The largest positive pair is helix 1’ to helix 3’, which is also mainly all
positive. The intermonomer alpha carbon correlations are almost all mixed. Helix 1 to
helix 2’ and helix 2 to helix 2’ are largely negative. The helix 3 to helix 3’ pair is mixed,
with the outermost residues (between 65 and 70) negative, and the innermost residues (54
to 60) positive.

A.

B.

Figure 4.7. Correlation matrices for the entire simulation and first 10ns of run5. A: the entire
50ns. B: the first 10ns.

The breaking of the salt bridge between D29 and R46’ observed in run5 is also
when residues R38 and R38’ are the closest, suggesting a relationship between these two
events. Analyzing the correlations between residue D29 (29), R38 (38), R38’ (111), and
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R46’ (119) before the breaking of the D29-R46’ salt bridge (Figure 4.7, left panel), the
following correlations are observed: D29 to R38, slightly negative; D29 to R38’,
negative; D29 to R46’, highly negative; R38 to R38’, highly negative; R38 to R46’,
negative; R38’ to R46’, highly positive.

A.

B.

C.

D.

Figure 4.8. Correlation matrices for 10ns time frames of run5. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.

During the time frame directly after the breaking of the salt bridge (Figure 4.8A)
the following correlations occur: D29 to R38, slightly negative; D29 to R38’, slightly
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negative; D29 to R46’, slightly negative; R38 to R38’, slightly negative; R38 to R46’,
negative; R38’ to R46’, slightly positive. Most correlations during this time frame are
smaller in magnitude, indicating less correlation between the motions of the residues. The
intramonomer alpha carbon correlations are all positive, with the largest positive pair
occurring between helix 1 to helix 3 and helix 1’ to helix 3’. The correlation between
these pairs was weaker before the breaking of the salt bridge. The intermonomer alpha
carbon correlations are mainly mixed, with the exception of helix 3 to helix 3’, which is
largely negative. The subsequent time frames (Figures 4.8B, C and D) have weaker
correlations as the simulation progresses. Similar correlations were observed for the time
frames before and after the breaking event for the other trajectories (Appendix D). The
anticorrelated motion of helix 3 to helix 3’ is attributed to the helices sliding along the
cross that they form with each other (Figure 1.2, left panel), while motions in the other
parts of the protein are taking place. Helices 3 and 3’ are rich in glutamic acid and lysine
residues, whereby the sliding can occur without a significant change of intermonomer
interactions. This sliding is important for dimer stability, because the monomers can flex
without the dimer coming apart.

4.5 Eigenvectors
The components of the eigenvectors for the three lowest eigenvalues of the
motion of the RBD for run5 are plotted in Figures 4.9 and 4.10. The terminal residues of
each monomer are expected to have larger contributions to motion during the entire 50ns
of the simulation (Figure 4.9, left panel) because they have more flexibility. The first
eigenvector for the first 10ns has stronger contributions from the C-terminal residues
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(Figure 4.9, right panel). The second and third eigenvectors have large contributions from
D29 (and its surrounding residues) and R46’ (and its surrounding residues) in agreement
with the results in Figure 4.3. They also contain contributions from helices 2 and 2’
(second eigenvector), and helices 1, 2, and 2’, and the turn between 1’ and 2’ (third
eigenvector).

A.

B.

Figure 4.9. Eigenvectors for the entire simulation and first 10ns of run5. A: the entire 50ns. B:
the first 10ns.

The eigenvectors of the correlation matrix obtained for the time frame directly
after the breaking of the salt bridge is dominated by the motion of terminal residues with
very small contributions from the rest of the protein (Figure 4.10A). The rest of the time
frames from run5 (Figure 4.10B, C, and D) display motion dominated by the terminal
residues and D29 (and its surrounding residues). The results for the other simulations are
similar in the time frame during the salt bridge D29-R46’ breaks the eigenvectors are
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dominated by D29 (and its surrounding residues) and helices 2 and 2’ and after the salt
bridge breaks these residues have a smaller contribution (Appendix E).

A.

B.

C.

D.

Figure 4.10. Eigenvectors for 10ns time frames of run5. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.

4.6 Normal Mode Analysis
In order to corroborate that the anticorrelated motion between helices 2 and 2’ is a
physically relevant fluctuation for the RBD, NMA was performed on the initial NMR
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structure used in the MD simulations. The motion of the lowest frequency vibrational
mode has been represented in Figures 4.11 and 4.12 as initial (green) and final (brown)
structures. The only difference between Figures 4.11 and 4.12 is the orientation.

Figure 4.11. Side view of superimposed molecular representations of the NS1 dimer from NMA
and MD. Left panel: the initial (green) and final (brown) conformations associated with the first
normal mode of vibration of the dimer. Right panel: conformations extracted from run5 at 5ns
(green) and 29ns (brown).

The left panel of Figure 4.11 is an overlay of the initial configuration (green) and
the final configuration (brown) from the first normal mode in run5. The right panel is an
overlay of a snapshot of the protein before the breaking of the D29-R46’ salt bridge
(green) and a snapshot of the protein after the salt bridge breaks (brown) in run5. The
motions observed in the MD simulation resemble the motions associated with the lowest
frequency normal mode of vibration. A change observed in the normal mode motion
(Figure 4.12) is that the C-terminal of helix 2 is moving away from the N-terminal of
helix 2’, and the C-terminal of helix 2’ is moving away from the N-terminal of helix 2.
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The MD snapshots have a similar change. Also, the middle residues of helices 2 and 2’
are moving away from each other, giving both helices a slightly concave shape.

Figure 4.12. Bottom view of superimposed molecular representations of the NS1 dimer from
NMA and MD. Color scheme and parameters are the same as Figure 4.11.

The residue contributions for the first three normal modes of vibration derived
from the NMR structure of RBD are depicted in Figure 5.3. These results were
determined using the same PCA algorithm used in the MD simulations to make
comparison with MD results (Figures 4.7) more straightforward. The first normal mode is
dominated by motions of residues in helices 2, 1’, and 2’, specifically the last several
residues of helices 2 and 2’. The second mode is dominated by contributions from helices
2 and the turn between helices 1’ and 2’, while the third is dominated by the turn between
helices 1 and 2, the last few residues of helix 2’, and the turn between helices 2’ and 3’.

38

D29 is located in the turn between helices 1 and 2, and R46’ is one of the last few
residues of helix 2’.

Figure 4.13. Residue contributions of the first eigenvector for the three lowest energy normal
modes of vibration.
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Chapter Five
Discussion

To validate the NMR structure used for MD, heavy atom RMSD was calculated
for an array of structures. The initial structure, 1NS1 model 1, was compared to related xray structures from the PDB, snapshots from MD and NMA, and the average of all 16
NMR structures (Figure 5.1). The RMSD of model 1 is 1.001Å to 1AIL and 1.05Å to
2ZKO, values that confirm model 1 as a valid initial structure. To mimic the intracellular
environment of NS1, 0.1M KCl was added to the protein and water box. The effect of salt
concentration on the RBD was studied, by running 100ns simulations with varying
concentration, specifically 0, 0.01, 0.05, 0.1, 0.5, 1, and 5M KCl, to ensure no bias was
introduced by the salt or specific concentration used in this study. Interestingly,
simulations with factor-of-5 concentration values (0.05, 0.5, and 5.0M KCl) displayed
very small motions, relative to the other salt concentrations. This seems to be an artifact
of the salt addition, so factor-of-1 concentrations were compared to 0M KCl. Protein
motion dependence on salt concentration was determined. Residue motions were the
highest in the 0 and 0.01M KCl simulations. The simulations with 0.1 and 1.0M KCl
concentrations had motions that were moderate compared to the large motions of 0 and
0.1M. While either 0.1 or 1.0M would be an acceptable concentration for simulations
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with biological molecules, 0.1M is the intracellular salt concentration and no bias was
found, therefore 0.1M KCl is the appropriate salt concentration.
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Figure 5.1. RMSD comparing 16 1NS1 NMR structures, 1AIL and 2ZKO x-ray structures, and
snapshots from MD and NMA.

The breaking of the D29-R46’ salt bridge is a significant event observed almost
all of the RBD trajectories (Figure 4.3 and Appendix A). . In the simulation where the
salt bridge did not break, the cavity volume did not appreciably change. This salt bridge
is essential for dimerization (Wang), and therefore required for RNA binding. The salt
bridge is solvent exposed and a target for a small molecule to potentially disrupt RNA
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binding. The cavity formed by helices 2 and 2’ has been identified as a target for antiviral
drugs directed at the influenza virus (Yin). To investigate whether this salt bridge is intact
upon RNA binding, one 100ns simulation was performed on 2ZKO, which revealed that
this salt bridge is not intact (~5Å interaction distance) during most of the trajectory. R46’
is involved in the interaction with RNA, and once dimerization occurs, this and other salt
bridges stabilize the dimer, allowing flexibility in the D29-R46’ interaction. A recent
study has also performed MD simulations on 2ZKO, trying to determine the energetic
contributions important residues have on RNA binding interactions and giving the
hydrophobic binding pocket residues as the most important targets for drug molecules
(Pan).
The work here focused instead on charged residues in the RNA binding cavity of
1NS1. There is a strong correlation between the first breaking of the salt bridge and
changes of size and shape of the cavity. The distance between residues R38 and R38’ was
used first as a crude measure of the size of the cavity, while changes of its shape are
described by the surrounding residues. As observed in Figure 4.2, while R38 and R38’
are farther apart, the cavity is open at the center, but when they come closer together, the
cavity is essentially cut in half from the top and becomes concave in shape. The change
in cavity volume during the simulation, going from a smaller volume when R38 and R38’
are farther apart to a larger volume when these two residues get closer together, is
attributed to the anticorrelated motion of helices 2 and 2’ (Figure 4.12). With the helices
farther apart, there is more volume on the interior of the cavity, as well as more volume
around the location of the broken salt bridge. When RNA is bound to the RBD, residues
R38 and R38’ are closed over the cavity rim during the entire trajectory. The CASTp
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server was used to calculate the volume of the cavity of the pdb structure, as well as
structures through the simulation (Figure 4.4 and Appendix B). For the two simulations
that were analyzed, the smallest cavity volume occurs before the breaking of the salt
bridge, with a volume near 400Å3. After the salt bridge breaks, the cavity has a volume
near 1000Å3, which is the largest cavity volume during the simulations.
The anticorrelated motion of helix 3 to helix 3’ (Figures 4.7 and 4.8) is attributed
to the helices sliding along the cross that they form with each other (Figure 1.2), while
motions in the other parts of the protein are taking place. Helices 3 and 3’ are rich in
glutamic acid and lysine residues, whereby the sliding can occur without a significant
change of intermonomer interactions. This sliding is important for dimer stability,
because the monomers can flex without coming apart. Correlations occurring before and
during the D29-R46’ salt bridge breaking event are very different than the correlations
after the breaking event, a trend in all trajectories (Figures 4.7 - 4.10 and Appendices D
and E). The salt bridge breaks with the motion of helices 2 and 2’, which is clearly
displayed in Figure 4.3. The largest anticorrelated motion is between helix 2 and helix 2’,
where the helices are moving away from each other. This motion is another significant
event in the simulations that disrupts the shape and size of the binding cavity.
In order to corroborate that the anticorrelated motion between helices 2 and 2’ is a
physically relevant fluctuation for RBD, NMA was performed on the initial NMR
structure used in the MD simulations. The motion of the lowest frequency vibrational
mode has been represented as initial (green) and final (brown) structures. The left panels
of Figures 4.12 and 4.13 are different orientations of the first NM, while the right panels
depict structures of the protein before (green) and after (brown) the breaking of the D2943

R46’ salt bridge during run5. The motions observed in the MD simulation resemble the
motions associated with the lowest frequency mode of vibration. A change observed in
the normal mode motion is that the C-terminal of helix 2 is moving away from the Nterminal of helix 2’, and the C-terminal of helix 2’ is moving away from the N-terminal
of helix 2. The MD structures have a similar change. Also, the middle residues of helices
2 and 2’ are moving away from each other, giving both helices a slightly concave shape.
The MD trajectory correlations for helix 2 to helix 2’ depicted in Figures 4.7 and 4.8 are
largely negative. This agrees with the motion described by the three lowest frequency
vibrational modes, with the ends of helix 2 and 2’ moving away from each other.
The residue contributions for the first eigenvector of each of the three lowest
energy modes of vibration derived from the NMR structure of RBD are depicted in
Figure 4.13. The first normal mode is dominated by motions of residues in helices 2, 1’,
and 2’, specifically the last several residues of helices 2 and 2’. The second mode is
dominated by contributions from helices 2 and the turn between helices 1’ and 2’, while
the third is dominated by the turn between helices 1 and 2, the last few residues of helix
2’, and the turn between helices 2’ and 3’. D29 is located in the turn between helices 1
and 2, and R46’ is one of the last few residues of helix 2’. There are qualitative
similarities between NMA residue contributions from the two lowest energy modes and
contributions from the second and third eigenvector of the MD trajectory of RBD before
D29-R46’ breaks (Figures 4.13, 4.9, and 4.10).
The breaking of the D29-R46’ salt bridge and R38-R38’ fluctuations are assisted
by the formation of hydrogen bonds with water molecules. The average total number of
hydrogen bond interactions for D29 is 8 for the first 35ns, (Figure 4.5A and C), while for
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R46’ the average total is 7 for the first 35ns (Figure 4.5B and C). During the first 10ns for
R46’, the average total is 8, which may be a factor in the breaking of the salt bridge. The
8th interaction may affect the stability of the salt bridge, aiding the breaking, such that
R46’ pushes away from D29 in order to reduce the number of hydrogen bond
interactions. When R38 and R38’ are farther apart (Figure 4.3A), the average total
number of hydrogen bonds is 8, but when they are closer together, the average total is
less, either 6 or 7 (Figures 4.6 Appendix C), suggesting that these arginine residues prefer
8 hydrogen bonds, and when that number is not satisfied (when the residues are close
together), R38 and R38’ react by forming intramonomer hydrogen bonds, causing them
to move farther apart. For the RNA bound RBD structure, negatively charged phosphate
groups of RNA interact with positively charged RBD residues, helping to satisfy the 8
hydrogen bonds for arginine.
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Chapter Six
Conclusion

The salt bridge, D29-R46’, is essential for dimerization and RNA binding, making
it a possible interaction site for a small molecule. Targeting this salt bridge only will not
affect dimer stability, but if this salt bridge and its mirror image, D29’-R46, are targeted,
dimer stability could be affected. Correlated motions occur before and during the D29R46’ salt bridge breaking event with helices 2 and 2’, where the helices are moving away
from each other. MD trajectory motions are consistent with NMA during the breaking of
the D29-R46’ salt bridge. Motions after the breaking are dominated by correlated
movement of helices 1 (1’) and 3 (3’). This salt bridge is clearly important to dimer
motions and stability.
The size and shape of the RNA binding cavity formed by helices 2 and 2’ is
facilitated by RBD intermonomeric salt bridges. These salt bridges maintain dimer
flexibility while the cavity size and shape changes. There is correlation between D29R46’ breaking, flexibility in the R38 and R38’ side chains, and changes of the RNA
binding cavity size and shape. Residues R38 and R38’ form a lid over the cavity with
increased volume when the salt bridge is broken, the larger volume attributed to the
anticorrelated helices 2 and 2’ motion. These interactions without RNA are mediated by
hydrogen bonds formed with solvent water molecules. When RNA is bound, the
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positively charged residues of the binding cavity interact with the negatively charged
RNA phosphate groups. This correlated salt bridge – cavity covering is an attractive drug
target against RNA binding.
Open and closed RNA binding cavity conformations are reached during the time
frame of the 1NS1 simulations, without RNA. This suggests that the RBD is switching
from the open and closed conformations, and when RNA approaches, if the cavity is in
the closed conformation, it will bind, and when the cavity is open, no binding occurs.
When RNA is bound, in 2ZKO, the cavity is locked in the closed conformation,
confirming the importance of the positively charged residues that comprise the binding
cavity.
Results reported here may help design of a drug molecule for the NS1 protein,
specifically targeting RBD. If a molecule could be developed to target residues R38 and
R38’ and impede the closing of the cavity, this might disrupt RNA binding to the RBD.
Another interesting target is one of the solvent exposed intermonomeric salt bridges that
facilitate dimer stability. The problem with current antivirals is that the virus target
protein mutates rapidly, rendering the drug ineffective. New antivirals must be developed
each year. Due to the high level of conservation in RBD across influenza A strains,
residue mutations occur slowly. When drugs are developed against RBD, the slow
mutation rate should help drug efficacy last longer than current antivirals.
The next step in drug development targeting RBD is flexible docking of the RBD
to identify functional groups of existing drug molecules that interact favorably with the
RNA binding cavity, specifically residues R38 and R38’ or D29-R46’. To achieve a
dynamics picture of the full-length NS1 protein, MD should be run on RBD bound to the
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effector domain, with and without RNA. This could identify additional potential targets
for drug molecules.
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Appendices

Appendix A Dimer Distances at 298K
A.1 Run1

A.

B.

C.

D.

Figure A.1. Distance versus time for run1. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
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atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).

A.2 Run2

A.

B.

C.

D.

Figure A.2. Distance versus time for run2. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.3 Run3

A.

B.

C.

D.

Figure A.3. Distance versus time for run3. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.4 Run4

A.

B.

C.

D.

Figure A.4. Distance versus time for run4. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.5 Run6

A.

B.

C.

D.

Figure A.5. Distance versus time for run6. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.6 Run7

A.

B.

C.

D.

Figure A.6. Distance versus time for run7. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.7 Run8

A.

B.

C.

D.

Figure A.7. Distance versus time for run8. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.8 Run9

A.

B.

C.

D.

Figure A.8. Distance versus time for run9. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.9 IR1run1

A.

B.

C.

D.

Figure A.9. Distance versus time for IR1run1. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.10 IR1run2

A.

B.

C.

D.

Figure A.10. Distance versus time for IR1run2. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.

B.

C.

D.

Figure A.11. Distance versus time for IR1run2; first 45ns only. A: distance between one of the
terminal amine nitrogen atoms of residue R38 and R38’. B: distance between one of the
carboxylic oxygen atoms of residue D29 (D29’) and one of the amine nitrogen atoms of residue
R46’ (R46). C: distance between one of the carboxylic oxygen atoms of residue D12 (D12’) and
one of the amine nitrogen atoms of residue R35’ (R35). D: distance between one of the
carboxylic oxygen atoms of residue D39 (D39’) and one of the amine nitrogen atoms of residue
R35’ (R35).
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A.11 IR1run3

A.

B.

C.

D.

Figure A.12. Distance versus time for IR1run3. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.12 IR2run1

A.

B.

C.

D.

Figure A.13. Distance versus time for IR2run1. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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A.13 IR3run1

A.

B.

C.

D.

Figure A.14. Distance versus time for IR3run1. A: distance between one of the terminal amine
nitrogen atoms of residue R38 and R38’. B: distance between one of the carboxylic oxygen atoms
of residue D29 (D29’) and one of the amine nitrogen atoms of residue R46’ (R46). C: distance
between one of the carboxylic oxygen atoms of residue D12 (D12’) and one of the amine nitrogen
atoms of residue R35’ (R35). D: distance between one of the carboxylic oxygen atoms of residue
D39 (D39’) and one of the amine nitrogen atoms of residue R35’ (R35).
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Appendix B Cavity Volume of Selected Runs at 298K

B.1 Run2

Figure B.1. Cavity volume for run2 calculated with the CASTp server.

B.2 Run3

Figure B.2. Cavity volume for run3 calculated with the CASTp server.
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Appendix C Dimer Hydrogen Bonds at 298K

C.1 Run1

A.

B.

C.

D.

Figure C.1. Hydrogen bonds for selected salt bridge residues of run1. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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A.

B.

Figure C.2. Hydrogen bonds for residues R38 and R38’ of run1. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.2 Run2

A.

B.

C.

D.

Figure C.3. Hydrogen bonds for selected salt bridge residues of run2. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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A.

B.

Figure C.4. Hydrogen bonds for residues R38 and R38’ of run2. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.3 Run3
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Figure C.5. Hydrogen bonds for selected salt bridge residues of run3. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.6. Hydrogen bonds for residues R38 and R38’ of run3. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.4 Run4
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Figure C.7. Hydrogen bonds for selected salt bridge residues of run4. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.8. Hydrogen bonds for residues R38 and R38’ of run4. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.5 Run6
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Figure C.9. Hydrogen bonds for selected salt bridge residues of run6. A: hydrogen bonds formed
by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed by
residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.

75

A.

B.

Figure C.10. Hydrogen bonds for residues R38 and R38’ of run6. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.6 Run7
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Figure C.11. Hydrogen bonds for selected salt bridge residues of run7. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.12. Hydrogen bonds for residues R38 and R38’ of run7. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.7 Run8
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Figure C.13. Hydrogen bonds for selected salt bridge residues of run8. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.14. Hydrogen bonds for residues R38 and R38’ of run8. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.8 Run9
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Figure C.15. Hydrogen bonds for selected salt bridge residues of run9. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.16. Hydrogen bonds for residues R38 and R38’ of run9. A: hydrogen bonds formed by
residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen bonds.
Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.9 IR1run1
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Figure C.17. Hydrogen bonds for selected salt bridge residues of IR1run1. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.18. Hydrogen bonds for residues R38 and R38’ of IR1run1. A: hydrogen bonds formed
by residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.10 IR1run2

A.

B.

C.

D.

Figure C.19. Hydrogen bonds for selected salt bridge residues of IR1run2. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.20. Hydrogen bonds for residues R38 and R38’ of IR1run2. A: hydrogen bonds formed
by residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.21. Hydrogen bonds for selected salt bridge residues of IR1run3. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.22. Hydrogen bonds for residues R38 and R38’ of IR1run3. A: hydrogen bonds formed
by residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.23. Hydrogen bonds for selected salt bridge residues of IR2run1. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.24. Hydrogen bonds for residues R38 and R38’ of IR2run1. A: hydrogen bonds formed
by residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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C.13 IR3run1
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Figure C.25. Hydrogen bonds for selected salt bridge residues of IR3run1. A: hydrogen bonds
formed by residue D29. B: hydrogen bonds formed by residue R46’. C: hydrogen bonds formed
by residue D29’. D: hydrogen bonds formed by residue R46. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.
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Figure C.26. Hydrogen bonds for residues R38 and R38’ of IR3run1. A: hydrogen bonds formed
by residue R38. B: hydrogen bonds formed by residue R38’. Intra: intramonomer hydrogen
bonds. Inter: intermonomer hydrogen bonds. Water: hydrogen bonds with water.

92

Appendix D Dimer Correlation Matrices at 298K

D.1 Run1

A.

B.

Figure D.1. Correlation matrices for the entire simulation and first 10ns of run1. A: the entire
50ns. B: the first 10ns.
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Figure D.2. Correlation matrices for 10ns time frames of run1. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.2 Run2
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Figure D.3. Correlation matrices for the entire simulation and first 10ns of run2. A: the entire
50ns. B: the first 10ns.
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Figure D.4. Correlation matrices for 10ns time frames of run2. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.3 Run3
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Figure D.5. Correlation matrices for the entire simulation and first 10ns of run3. A: the entire
50ns. B: the first 10ns.
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Figure D.6. Correlation matrices for 10ns time frames of run3. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.4 Run4
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Figure D.7. Correlation matrices for the entire simulation and first 10ns of run4. A: the entire
50ns. B: the first 10ns.
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Figure D.8. Correlation matrices for 10ns time frames of run4. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.5 Run6
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Figure D.9. Correlation matrices for the entire simulation and first 10ns of run6. A: the entire
50ns. B: the first 10ns.
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Figure D.10. Correlation matrices for 10ns time frames of run6. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.6 Run7
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Figure D.11. Correlation matrices for the entire simulation and first 10ns of run7. A: the entire
50ns. B: the first 10ns.
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Figure D.12. Correlation matrices for 10ns time frames of run7. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.7 Run8
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Figure D.13. Correlation matrices for the entire simulation and first 10ns of run8. A: the entire
50ns. B: the first 10ns.
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Figure D.14. Correlation matrices for 10ns time frames of run8. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.8 Run9
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Figure D.15. Correlation matrices for the entire simulation and first 10ns of run9. A: the entire
50ns. B: the first 10ns.
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Figure D.16. Correlation matrices for 10ns time frames of run9. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.9 IR1run1
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Figure D.17. Correlation matrices for the entire simulation and first 10ns of IR1run1. A: the
entire 50ns. B: the first 10ns.
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Figure D.18. Correlation matrices for 10ns time frames of IR1run1. A: the second 10ns. B: the
third 10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.10 IR1run2
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Figure D.19. Correlation matrices for the entire simulation and first 10ns of IR1run2. A: the
entire 50ns. B: the first 10ns.
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Figure D.20. Correlation matrices for 10ns time frames of IR1run2. A: the second 10ns. B: the
third 10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.11 IR1run3
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Figure D.21. Correlation matrices for the entire simulation and first 10ns of IR1run3. A: the
entire 50ns. B: the first 10ns.
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Figure D.22. Correlation matrices for 10ns time frames of IR1run3. A: the second 10ns. B: the
third 10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.12 IR2run1
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Figure D.23. Correlation matrices for the entire simulation and first 10ns of IR2run1. A: the
entire 50ns. B: the first 10ns.
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Figure D.24. Correlation matrices for 10ns time frames of IR2run1. A: the second 10ns. B: the
third 10ns. C: the fourth 10ns. D: the fifth 10ns.
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D.13 IR3run1
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Figure D.25. Correlation matrices for the entire simulation and first 10ns of IR3run1. A: the
entire 50ns. B: the first 10ns.
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Figure D.26. Correlation matrices for 10ns time frames of IR3run1. A: the second 10ns. B: the
third 10ns. C: the fourth 10ns. D: the fifth 10ns.
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Appendix E Eigenvectors for 1NS1 at 298K

E.1 Run1
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Figure E.1. Eigenvectors for the entire simulation and first 10ns of run1. A: the entire 50ns. B:
the first 10ns.
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Figure E.2. Eigenvectors for 10ns time frames of run1. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.2 Run2
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Figure E.3. Eigenvectors for the entire simulation and first 10ns of run2. A: the entire 50ns. B:
the first 10ns.
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Figure E.4. Eigenvectors for 10ns time frames of run2. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.3 Run3
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Figure E.5. Eigenvectors for the entire simulation and first 10ns of run3. A: the entire 50ns. B:
the first 10ns.
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Figure E.6. Eigenvectors for 10ns time frames of run3. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.4 Run4
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Figure E.7. Eigenvectors for the entire simulation and first 10ns of run4. A: the entire 50ns. B:
the first 10ns.
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Figure E.8. Eigenvectors for 10ns time frames of run4. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.5 Run6
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Figure E.9. Eigenvectors for the entire simulation and first 10ns of run6. A: the entire 50ns. B:
the first 10ns.
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Figure E.10. Eigenvectors for 10ns time frames of run6. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.6 Run7
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Figure E.11. Eigenvectors for the entire simulation and first 10ns of run7. A: the entire 50ns. B:
the first 10ns.
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Figure E.12. Eigenvectors for 10ns time frames of run7. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.7 Run8
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Figure E.13. Eigenvectors for the entire simulation and first 10ns of run8. A: the entire 50ns. B:
the first 10ns.
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Figure E.14. Eigenvectors for 10ns time frames of run8. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.8 Run9
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Figure E.15. Eigenvectors for the entire simulation and first 10ns of run9. A: the entire 50ns. B:
the first 10ns.
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Figure E.16. Eigenvectors for 10ns time frames of run9. A: the second 10ns. B: the third 10ns. C:
the fourth 10ns. D: the fifth 10ns.
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E.9 IR1run1
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Figure E.17. Eigenvectors for the entire simulation and first 10ns of IR1run1. A: the entire 50ns.
B: the first 10ns.
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Figure E.18. Eigenvectors for 10ns time frames of IR1run1. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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Figure E.19. Eigenvectors for the entire simulation and first 10ns of IR1run2. A: the entire 50ns.
B: the first 10ns.
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Figure E.20. Eigenvectors for 10ns time frames of IR1run2. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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E.11 IR1run3
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Figure E.21. Eigenvectors for the entire simulation and first 10ns of IR1run3. A: the entire 50ns.
B: the first 10ns.
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Figure E.22. Eigenvectors for 10ns time frames of IR1run3. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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E.12 IR2run1
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Figure E.23. Eigenvectors for the entire simulation and first 10ns of IR2run1. A: the entire 50ns.
B: the first 10ns.
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Figure E.24. Eigenvectors for 10ns time frames of IR2run1. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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E.13 IR3run1
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Figure E.25. Eigenvectors for the entire simulation and first 10ns of IR3run1. A: the entire 50ns.
B: the first 10ns.
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Figure E.26. Eigenvectors for 10ns time frames of IR3run1. A: the second 10ns. B: the third
10ns. C: the fourth 10ns. D: the fifth 10ns.
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